IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSNATI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.738
EU - Europa 7.028
AS - Asia 3.172
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 13
OC - Oceania 10
Totale 20.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.709
PL - Polonia 3.373
CN - Cina 1.585
UA - Ucraina 1.272
DE - Germania 613
SG - Singapore 586
IT - Italia 519
HK - Hong Kong 468
FI - Finlandia 327
GB - Regno Unito 244
IE - Irlanda 212
TR - Turchia 209
RU - Federazione Russa 179
VN - Vietnam 124
FR - Francia 117
IN - India 97
CZ - Repubblica Ceca 49
ID - Indonesia 42
SE - Svezia 28
BE - Belgio 25
CA - Canada 25
IR - Iran 19
NL - Olanda 17
EU - Europa 14
ES - Italia 13
AU - Australia 10
MU - Mauritius 9
IL - Israele 7
MA - Marocco 7
BR - Brasile 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
EE - Estonia 4
LT - Lituania 4
SA - Arabia Saudita 4
AT - Austria 3
CH - Svizzera 3
CL - Cile 3
EC - Ecuador 3
JP - Giappone 3
KR - Corea 3
KZ - Kazakistan 3
PK - Pakistan 3
PT - Portogallo 3
ZA - Sudafrica 3
AL - Albania 2
BD - Bangladesh 2
BG - Bulgaria 2
HU - Ungheria 2
IQ - Iraq 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GR - Grecia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SM - San Marino 1
TH - Thailandia 1
Totale 20.998
Salva come PNG Salva come JPEG
Città #
Warsaw 3.372
Fairfield 1.667
Woodbridge 1.275
Jacksonville 955
Houston 870
Ashburn 752
Cambridge 711
Ann Arbor 605
Wilmington 599
Seattle 566
Chandler 503
Singapore 475
Hong Kong 466
Princeton 397
Nanjing 346
Beijing 279
Dublin 210
New York 183
Istanbul 177
Dearborn 154
Helsinki 150
Nanchang 125
Dong Ket 122
Brescia 107
Moscow 96
San Diego 85
Shenyang 83
Des Moines 80
Jinan 79
Hebei 74
Boardman 71
Changsha 71
Jiaxing 65
Milan 64
Lancaster 62
Tianjin 58
Shanghai 55
Kunming 46
Jakarta 41
Hangzhou 40
London 36
Verona 34
San Mateo 32
Augusta 30
Munich 30
Rome 29
San Francisco 29
Brno 27
Haikou 27
Lanzhou 25
Leawood 25
Los Angeles 25
Phoenix 25
Zhengzhou 25
Kocaeli 24
Ningbo 24
Brussels 22
Norwalk 22
Olomouc 20
Taizhou 18
Taiyuan 17
Changchun 16
Fuzhou 16
Guangzhou 16
Monmouth Junction 16
Toronto 16
Ardabil 14
Kilburn 14
Parma 14
Florence 11
Hefei 11
Redwood City 11
Orange 10
Falls Church 9
Indiana 8
Beersheba 6
Dronten 6
Southwark 6
Washington 6
Amsterdam 5
Markham 5
Melbourne 5
New Bedfont 5
Padova 5
Siena 5
Wandsworth 5
Acton 4
Auburn Hills 4
Catania 4
Como 4
Falkenstein 4
Lanciano 4
Lappeenranta 4
Madrid 4
Nuremberg 4
Riyadh 4
Tallinn 4
Almaty 3
Barcelona 3
Bernareggio 3
Totale 16.976
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 279
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures. 265
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 251
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 244
Biological role of immunoglobulin Free light chains interactomes 241
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 237
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 231
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 231
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 230
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 227
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 226
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 225
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 223
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 217
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 217
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 216
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 215
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 211
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 209
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 207
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 206
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 203
The FGF2-binding domain of thrombospondin-1: functional characterization and exploitation to design antiangiogenic compounds 195
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 188
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 185
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 184
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 184
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 181
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 177
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 168
Chemoselective surface immbolization of proteins through a cleavable peptide 168
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 165
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 165
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 160
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 156
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 153
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 149
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 147
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 142
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 134
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 131
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 129
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 129
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 128
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 126
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 124
Sialic acid as a target for the development of novel antiangiogenic strategies 124
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 123
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 122
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 121
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 120
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 120
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 118
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 118
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 117
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 117
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 116
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 115
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 115
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 114
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 113
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 113
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 112
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 112
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 111
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 109
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells. 109
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 109
Targeting fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis 107
Heparin derivatives as angiogenesis inhibitors 106
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 106
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. 106
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 106
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 105
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. 105
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 105
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 105
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 103
Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. 102
The Impact of Surface Plasmon Resonance in Virology 102
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 101
High molecular weight immunoreactive basic fibroblast growth factor-like proteins in rat pituitary and brain. 101
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 100
Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans 99
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 99
Interaction of angiogenic growth factors with endothelial cell heparan sulfate proteoglycans: implications for the development of angiostatic compounds 99
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 99
The colloidal side of cell communication. 99
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 99
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 98
Liver DNA damage by chemical carcinogens: role of thyroid hormones 98
Multispot, label-free biodetection at a phantom plastic-water interface. 98
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery. 98
Dendritic cell-endothelial cell cross-talk in angiogenesis. 97
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 96
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 95
Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 tat-induced angiogenesis and is poorly expressed in KS lesions 94
Fibroblast growth factor-2 in angiogenesis 94
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 94
Positively charged peptides can interact with each other as revealed by solid phase binding assays 93
Totale 14.536
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.125 0 0 0 0 0 0 615 622 468 810 276 334
2020/20213.605 110 383 122 489 185 394 136 423 458 280 409 216
2021/20221.785 93 423 30 43 24 69 123 119 84 235 141 401
2022/20231.409 219 59 56 93 106 382 9 149 198 18 48 72
2023/20241.549 93 30 137 68 67 235 52 69 403 49 40 306
2024/20251.306 47 23 18 493 356 286 83 0 0 0 0 0
Totale 21.392